FdaApplication
ANDA 216247
Identifiers
- fda_app_no: ANDA216247
Properties
| Property | Value |
|---|---|
| applicant_name | DEXCEL PHARMA TECHNOLOGIES LTD |
| application_type | ANDA |
| approval_date | 2023-06-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 40MG BASE | FOR SUSPENSION, DELAYED RELEASE;ORAL |
1 product